rethinkPeptides Search
Menu
Study breakdown

Probiotics Boost Antimicrobial Peptides While Calming Inflammation Against Pseudomonas Gut Infections

In Vitro (Infection Model)Preliminary evidence
The takeaway

Two probiotic strains enhanced beta-defensin 2 production while reducing inflammatory IL-8 in intestinal cells infected with Pseudomonas aeruginosa, through NOD1/Akt signaling.

Dual benefit

probiotics simultaneously boosted antimicrobial defense (hBD-2) and calmed inflammation (IL-8) against Pseudomonas

What the researchers found

Two probiotic strains (Lactobacillus rhamnosus GG and Bifidobacterium longum spp. infantis S12) produced a dual effect when administered to intestinal epithelial cells (SW480) before Pseudomonas aeruginosa infection:

hBD-2 was enhanced: probiotic pretreatment increased both mRNA expression and secreted protein of this antimicrobial peptide, strengthening the direct antimicrobial defense.

IL-8 was suppressed: the inflammatory chemokine IL-8 was reduced, meaning less inflammatory immune cell recruitment and less tissue damage.

The mechanism: probiotics enhanced P. aeruginosa-induced membranous NOD1 protein expression and Akt activation. When Akt or NOD1 were knocked down with siRNA, the probiotic effects on IL-8 and hBD-2 were both reversed. This confirms NOD1 and Akt are the regulatory nodes.

This reciprocal regulation (more antimicrobial defense, less inflammation) is the ideal immune response: kill the pathogen without destroying the tissue.

Why it matters

Pseudomonas aeruginosa can cause fatal sepsis, especially in young children. Antibiotics are the standard treatment but overuse drives resistance. Probiotics offer a complementary approach by boosting the body's own antimicrobial peptides while reducing the damaging inflammation that worsens disease. This dual action is more targeted than broad-spectrum antibiotics.

The numbers in context

2 probiotic strains; hBD-2 up, IL-8 down; NOD1 and Akt confirmed; siRNA knockdown reversed effects

How the study worked

In vitro cell culture study using SW480 intestinal epithelial cells. Cells were pretreated with probiotics, then infected with PAO1 Pseudomonas aeruginosa. IL-8 and hBD-2 measured at mRNA and protein levels. Akt and NOD1 signaling assessed. siRNA knockdown of Akt and NOD1 confirmed their roles.

Who was studied

SW480 intestinal epithelial cells infected with P. aeruginosa PAO1

What this study cannot tell us

In vitro only, using a single intestinal cell line (SW480). Real intestinal tissue has multiple cell types, a mucus layer, and commensal bacteria that could modify the response. The probiotics were given before infection (pretreatment), not during; whether they work after infection starts is unknown. Only one Pseudomonas strain was tested.

How to read the evidence

Preliminary evidence from a single cell line in vitro study. The dual mechanism is clearly demonstrated but lacks in vivo confirmation.

When this study was published

Published in 2020. Probiotic-AMP research continues to expand, with increasing focus on strain-specific effects.

The bigger picture

Pseudomonas can cause fatal sepsis, especially in children. Probiotics offer a complementary approach to antibiotics by boosting natural defenses while reducing harmful inflammation. The specific mechanism through NOD1/Akt provides targets for more potent probiotic-based therapies.

Questions still open

  • Would this protective effect work in living animals or humans?
  • Are specific probiotic strains better at this dual defense-enhancement?
  • Could probiotics be used preventively in ICU patients at risk for Pseudomonas infection?

Common questions

Can probiotics really help fight serious infections?
In this lab study, probiotics enhanced the gut's natural antimicrobial defenses while reducing harmful inflammation. Whether this translates to protection in actual patients requires clinical trials.
How do probiotics boost antimicrobial peptides?
The probiotics activated a specific immune sensor (NOD1) in gut cells through the Akt signaling pathway, which increased production of beta-defensin 2 — a natural antibiotic that kills harmful bacteria.

Read the original research

Beneficial effect of probiotics on Pseudomonas aeruginosa-infected intestinal epithelial cells through inflammatory IL-8 and antimicrobial peptide human beta-defensin-2 modulation.

Innate immunity, 26(7), 592-600

Citation

Huang, Fu-Chen; Lu, Yi-Ting; Liao, Yu-Hsuan. (2020). Beneficial effect of probiotics on Pseudomonas aeruginosa-infected intestinal epithelial cells through inflammatory IL-8 and antimicrobial peptide human beta-defensin-2 modulation.. Innate immunity, 26(7), 592-600. https://doi.org/10.1177/1753425920959410